Using advanced technology to identify heart rhythm risks in people with sleep apnea
Official title: Deep learning of awake and sleep electrocardiography to identify atrial fibrillation risk in sleep apnea
Funded at University of Washington · NIH-10758964 · Data updated 2026-11-12
This study is looking at how sleep apnea might affect heart rhythm problems, and it's for people with sleep apnea who want to understand their heart health better, using advanced technology to help identify those at higher risk.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | January 15, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $92,786 |
| NIH project number | 5R21HL167126-02 |
| Project ID | NIH-10758964 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with obstructive sleep apnea who may also be at risk for atrial fibrillation.
✕Less likely to help
Patients without obstructive sleep apnea or those who do not have risk factors for atrial fibrillation may not benefit from this research.
What this research studies
This research investigates the connection between obstructive sleep apnea (OSA) and atrial fibrillation (AF), a common heart rhythm disorder. By utilizing deep learning techniques on electrocardiography (ECG) data collected during both awake and sleep states, the study aims to better identify individuals with OSA who are at higher risk for developing AF. The researchers will analyze heart rate responses to OSA events to improve cardiovascular risk assessment, which could lead to more informed treatment decisions for patients. This approach seeks to enhance the understanding of how sleep disorders impact heart health.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and management of patients at risk for atrial fibrillation, potentially reducing morbidity and mortality associated with this condition.
How similar studies have gone: Previous studies have shown promise in using advanced metrics to assess cardiovascular risks associated with sleep apnea, indicating that this approach may yield valuable insights.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Kwon, Younghoon — University of Washington
- Study coordinator: Kwon, Younghoon
Related research
Other NIH-funded projects on the same topics.
-
Deep learning to predict obstruction site and guide sleep apnea treatment
A patient-focused project uses snoring sounds and AI to predict where your airway collapses during sleep and to guide personalized treatments.
-
Targeting atrial fibrillation with deep learning-guided drug discovery
A new NIH grant aims to use advanced computer methods to find safer, more effective drugs for atrial fibrillation that could reduce hospitalizations and improve quality of life.
-
Using deep learning to improve risk estimation for atrial fibrillation
This study is looking at a new way to better spot atrial fibrillation, a heart condition that can cause serious problems like strokes, by using smart technology on mobile heart monitors, so we can help more people at risk get the care they need.
-
Integrative histo-genomic analysis to guide cancer risk and targeted therapies with interpretable AI
Researchers are developing an advanced AI-powered approach to map genetic and cellular patterns across breast and cervical cancers to help tailor treatments.
-
Cardiomyocyte-fibroblast signaling in atrial fibrillation
A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.
-
Predicting how antimalarial drug resistance spreads with AI
A powerful AI model will be built to forecast how resistance to antimalarial drugs might spread in Africa and beyond, helping clinicians and public health teams stay ahead of outbreaks.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.